Bill Text: NY S06044 | 2021-2022 | General Assembly | Introduced

---

Bill Title: Directs the office of addiction services and supports to maintain an online directory of distributors of opioid antagonists.

Spectrum: Partisan Bill (Democrat 3-0)

Status: (Passed) 2021-10-07 - SIGNED CHAP.434 [S06044 Detail]

Download: New_York-2021-S06044-Introduced.html

---

                STATE OF NEW YORK
        ________________________________________________________________________

                                          6044

                               2021-2022 Regular Sessions

                    IN SENATE

                                     March 31, 2021
                                       ___________

        Introduced  by Sen. HARCKHAM -- read twice and ordered printed, and when
          printed to be committed to the Committee on Alcoholism  and  Substance
          Abuse

        AN  ACT  to  amend  the mental hygiene law, in relation to requiring the
          office of addiction services and supports to maintain an online direc-
          tory of distributors of opioid antagonists

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:

     1    Section  1.  Section  19.09  of  the  mental hygiene law is amended by
     2  adding a new subdivision (l) to read as follows:
     3    (l)(1) The office, in consultation  with  the  department  of  health,
     4  shall  maintain  on  its  website  a publicly available directory of all
     5  distributors of opioid antagonists to  the  public,  including  but  not
     6  limited to, pharmacies, prevention programs and not-for-profits. As used
     7  in  this subdivision, the following terms shall have the following mean-
     8  ings:
     9    (i) "Opioid" means  an  opiate  as  defined  in  section  thirty-three
    10  hundred two of the public health law.
    11    (ii)  "Opioid  antagonist"  means  a federal food and drug administra-
    12  tion-approved drug that, when administered, negates  or  neutralizes  in
    13  whole  or  in part the pharmacological effects of an opioid in the body.
    14  The opioid antagonist shall be limited to naloxone or other  medications
    15  approved by the department of health for this purpose.
    16    (2)  The  directory  required by this subdivision shall include and be
    17  searchable by the following information:
    18    (i) addresses of each distributor of opioid antagonists;
    19    (ii) contact information, such as phone numbers  or  email  addresses,
    20  for each distributor;
    21    (iii)  services  offered  by each distributor at each location if more
    22  than one, as well as information providing which opioid antagonists  are
    23  currently available at each distributor;

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD00343-01-1
        S. 6044                             2

     1    (iv) special populations served;
     2    (v) insurance providers accepted;
     3    (vi) hours of operation of each distributor;
     4    (vii) contact information of opioid addiction prevention programs; and
     5    (viii) any other information the commissioner deems necessary.
     6    (3)  The  office  may  utilize  an  existing  directory to satisfy the
     7  requirements of this subdivision.
     8    § 2. This act shall take effect on the one hundred eightieth day after
     9  it shall have become a law. Effective immediately, the addition,  amend-
    10  ment and/or repeal of any rule or regulation necessary for the implemen-
    11  tation  of  this act on its effective date are authorized to be made and
    12  completed on or before such effective date.